Landsberg Bennett & Dubbaneh’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$3.61M Buy
28,363
+667
+2% +$86.3K 0.46% 72
2021
Q2
$3.45M Buy
27,696
+6,490
+31% +$815K 0.45% 67
2021
Q1
$2.51M Buy
21,206
+17,654
+497% +$2.07M 0.36% 79
2020
Q4
$416K Sell
3,552
-2,165
-38% -$238K 0.06% 170
2020
Q3
$587K Buy
5,717
+1,206
+27% +$121K 0.1% 132
2020
Q2
$407K Buy
4,511
+27
+0.6% +$2.59K 0.08% 156
2020
Q1
$386K Buy
+4,484
New +$477K 0.11% 123

Other funds holding MDT

Landsberg Bennett & Dubbaneh's MDT Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh increased its Medtronic (MDT) stake by 2.4% in Q3 2021, buying an estimated $86.3K and bringing the position to 28,363 shares worth $3.61M. The position accounts for 0.46% of the portfolio, ranked #72.

Landsberg Bennett & Dubbaneh first reported a position in MDT in Q1 2020 and has held it in 7 quarters since. 2,024 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

  • Landsberg Bennett & Dubbaneh held 28,363 shares of Medtronic worth $3.61M as of Q3 2021.
  • Landsberg Bennett & Dubbaneh bought 667 Medtronic shares in Q3 2021, an estimated $86.3K.
  • Medtronic made up 0.46% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #72 holding.
  • Landsberg Bennett & Dubbaneh first reported a position in Medtronic in Q1 2020 and has held it in 7 quarters since.
  • 2,024 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.